Evaluation of the influence of systemic neoadjuvant chemotherapy on the survival of patients treated for invasive bladder cancer

BJU International

Volumn 89, Issue 6, 2002, Pages 616-619

  Kolaczyk, W ^a   Dembowski, J ^b,d   Lorenz, J ^b   Dudek, K ^c  

^a District Hospital   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Bladder; Invasive bladder cancer; Systemic chemotherapy

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BLADDER CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER SURVIVAL; CHRONOTHERAPY; CONTROLLED STUDY; CYSTECTOMY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOXORUBICIN; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM INVASIVENESS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0036349454     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2002.02689.x     Document Type: Article

References (13)

1. Cancerous disease in Poland in 1995
2. Urothelial tumours of the urinary tract
3. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium
4. Advances in the treatment of urothelial tract tumors
5. Neoadjuvant MVAC chemotherapy of invasive bladder cancer: Results of multicenter phase III trial
6. Neo-adjuvant CMV chemotherapy and cystectomy or radiation in muscle-invasive cancer: First analysis of MRC/EORTC Intercontinental Trial
7. Hydronephrosis as a prognostic indicator in bladder cancer patients
8. Neoadjuvant cisplatinum in locally advanced urothelial bladder cancer: A prospective randomised study of the group CUETO
9. Neoadjuvant cisplatin therapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: CUETO study 84005
10. Neoadjuvant chemotherapy in the treatment of invasive transitional bladder cancer: A controlled, prospective randomized study
11. Radical cystectomy for carcinoma of the urinary bladder: Critical evaluation of the results in 1026 cases
12. Primary methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and bladder preservation in locally invasive bladder cancer: 5-year follow-up